HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Karen Leroy Selected Research
Karen Leroy Research Topics
Disease
34
Neoplasms (Cancer)
12/2023 - 12/2002
8
Lymphoma (Lymphomas)
01/2019 - 08/2005
8
B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 04/2003
8
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2017 - 07/2004
8
Plexiform Neurofibroma
01/2014 - 06/2004
7
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 03/2016
6
Carcinoma (Carcinomatosis)
01/2020 - 01/2010
4
Carcinogenesis
01/2023 - 01/2007
4
Neurofibrosarcoma (MPNST)
01/2014 - 06/2004
3
Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2013
3
Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 01/2019
3
Lung Neoplasms (Lung Cancer)
10/2021 - 11/2019
3
Melanoma (Melanoma, Malignant)
11/2019 - 10/2006
3
Colonic Neoplasms (Colon Cancer)
02/2018 - 12/2002
3
Neurofibroma
11/2011 - 06/2004
3
Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2011 - 01/2007
2
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2021 - 02/2010
2
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2020 - 12/2002
2
Adenocarcinoma of Lung
05/2019 - 01/2019
2
Sarcoma (Soft Tissue Sarcoma)
10/2018 - 03/2011
2
Hodgkin Disease (Hodgkin's Disease)
08/2009 - 07/2004
1
Infections
01/2023
1
Adrenocortical Carcinoma
04/2022
1
Thyroid Neoplasms (Thyroid Cancer)
01/2022
1
Disease Progression
01/2022
1
Adenocarcinoma
12/2019
1
Inflammation (Inflammations)
11/2019
1
Renal Cell Carcinoma (Grawitz Tumor)
11/2019
1
Relapsing-Remitting Multiple Sclerosis
01/2019
1
Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019
1
Arthritis (Polyarthritis)
01/2019
1
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019
1
Ovarian Neoplasms (Ovarian Cancer)
10/2018
1
Sarcopenia
01/2017
1
Obesity
01/2017
1
Microsatellite Instability
03/2016
1
Neoplasm Metastasis (Metastasis)
07/2015
Drug/Important Bio-Agent (IBA)
10
DNA (Deoxyribonucleic Acid)
IBA
12/2019 - 12/2002
7
Messenger RNA (mRNA)
IBA
12/2023 - 04/2003
7
Proteins (Proteins, Gene)
FDA Link
01/2019 - 06/2004
6
Biomarkers (Surrogate Marker)
IBA
12/2023 - 07/2012
5
Paraffin
IBA
01/2023 - 11/2009
5
Rituximab (Mabthera)
FDA Link
11/2015 - 11/2009
4
Transcription Factors (Transcription Factor)
IBA
01/2019 - 06/2004
4
Antibodies
IBA
11/2018 - 01/2007
3
Nivolumab
IBA
12/2023 - 01/2017
3
Dimethyl Fumarate
IBA
01/2019 - 01/2017
3
Antioxidants
IBA
01/2019 - 01/2017
3
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
11/2017 - 04/2003
3
MicroRNAs (MicroRNA)
IBA
06/2014 - 01/2011
2
RNA (Ribonucleic Acid)
IBA
12/2023 - 11/2019
2
Formaldehyde (Formol)
FDA Link
01/2023 - 11/2019
2
N 30
IBA
01/2022 - 01/2020
2
Immune Checkpoint Inhibitors
IBA
01/2020 - 11/2019
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
02/2018 - 06/2012
2
Exportin 1 Protein
IBA
01/2018 - 01/2016
2
Prednisone (Sone)
FDA Link
Generic
12/2014 - 11/2009
2
Vincristine (Oncovin)
FDA Link
Generic
12/2014 - 11/2009
2
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2014 - 11/2009
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2014 - 11/2009
2
Chlorambucil (Leukeran)
FDA Link
05/2013 - 02/2010
2
Cytokines
IBA
11/2008 - 06/2004
1
Lipids
IBA
01/2023
1
Enzymes
IBA
01/2022
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2022
1
Citric Acid (Citrate)
FDA Link
Generic
01/2022
1
larotrectinib
IBA
01/2022
1
Circulating Tumor DNA
IBA
01/2022
1
Mitogen-Activated Protein Kinases
IBA
01/2022
1
Iodine
IBA
01/2022
1
Tyrosine Kinase Inhibitors
IBA
10/2021
1
Platinum
IBA
10/2021
1
Antigens
IBA
02/2021
1
A-Form DNA (A-DNA)
IBA
02/2021
1
CD40 Ligand (CD40L)
IBA
02/2020
1
Ligands
IBA
02/2020
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2020
1
B7-H1 Antigen
IBA
01/2020
1
Chromatin
IBA
01/2020
1
Colloids (Colloid)
IBA
12/2019
1
Secretin
FDA Link
12/2019
1
Anaplastic Lymphoma Kinase
IBA
05/2019
1
Exonucleases (3' 5' Exonuclease)
IBA
01/2019
1
Fumarates
IBA
01/2019
1
Cisplatin (Platino)
FDA Link
Generic
10/2018
1
Glutathione (Reduced Glutathione)
IBA
02/2018
1
Indicators and Reagents (Reagents)
IBA
11/2017
1
pembrolizumab
IBA
01/2017
1
Cytotoxins (Cytolysins)
IBA
01/2017
1
Anthracyclines
IBA
11/2015
1
Cetuximab (Erbitux)
FDA Link
07/2015
Therapy/Procedure
17
Therapeutics
01/2023 - 01/2007
7
Drug Therapy (Chemotherapy)
10/2021 - 12/2002
2
Genomic Medicine
01/2020 - 10/2018
2
Immunotherapy
01/2020 - 11/2019
2
Adjuvant Chemotherapy
01/2020 - 07/2015
2
Ligation
11/2017 - 04/2015
1
Molecular Targeted Therapy
05/2023
1
Radiotherapy
01/2020
1
Neoadjuvant Therapy
07/2015